pe
pep-05132 v1 CC-BY-SA-4.0

Chromogranin-A blood-sugar peptide

An experimental lab-made peptide aimed at the body's blood-sugar and appetite control switch, similar family as Ozempic-style drugs, but not approved.

statuscomputed targetGLP-1R length33 aa refs2
metabolic
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.758
pTM0.838
avg pLDDT74.9
ranking score0.751
STRUCTURE · PEP-05132 × GLP-1R
ranking0.751
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence33 aa
15101520253033
EEEEEEEEEAE AGEEAVPEEEG PTVVLNPHPSL
in the news 136 articles
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.7575963735580444 boltz-2
ranking score 0.7508533596992493 boltz-2
structural qualityopenfold3
metricvaluenote
gpde0.772global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Glu-Glu-Glu-Glu-Glu-Glu-Glu-Glu-Glu-Ala-Glu-Ala-Gly-Glu-Glu-Ala-Val-Pro-Glu-Glu-Glu-Gly-Pro-Thr-Val-Val-Leu-Asn-Pro-His-Pro-Ser-Leu
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). Chromogranin-A blood-sugar peptide (pep-05132, v1). PeptideModel. https://peptidemodel.com/card/pep-05132
@peptide{pep05132,
  sequence = {EEEEEEEEEAEAGEEAVPEEEGPTVVLNPHPSL},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 2 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use